Publication | Open Access
Secukinumab improves patient‐reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo‐controlled clinical trials
40
Citations
8
References
2016
Year
Secukinumab significantly improves patient-reported itching, pain, and scaling in adults with moderate to severe psoriasis compared with placebo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1